Page last updated: 2024-08-23

5'-palmitoyl cytarabine and Leukemia P388

5'-palmitoyl cytarabine has been researched along with Leukemia P388 in 2 studies

*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, SH; Berdel, WE; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR1
Hori, K; Naganuma, K; Sakurai, Y; Tsukagoshi, S; Tsuruo, T1

Other Studies

2 other study(ies) available for 5'-palmitoyl cytarabine and Leukemia P388

ArticleYear
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:10

    Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cytarabine; Drug Administration Schedule; Humans; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Solubility

1986
Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Cancer research, 1984, Volume: 44, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Animals; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasms, Experimental

1984